February 25-26, 2025
The Bellevue Hotel, Philadelphia, PAHybrid Event I Attend Live In-Person or Online Jenny PetersenSenior Director of Clinical Trial Disclosure and Transparency at AlnylamSpeaker
Profile
Jenny found her niche in Clinical Trial Transparency in 2007. A former wildlife biologist, Jenny transitioned to scientific publishing before entering the industry sector in the regulatory space in the early 2000s. She spent 10 years in Basel Switzerland, much of that time leading the Trial Disclosure activities at Hoffmann La-Roche, moving back to the US in 2015 to continue her career. Jenny is the Senior Director of Clinical Trial Disclosure and Transparency at Alnylam Pharmaceuticals.
Agenda Sessions
Examination of risk-based clinical document anonymization techniques and related processes to support PRCI and Policy 0070 submissions across a subsection of commercial sponsors and practical use cases.
, 1:30pmView Session